Treating Bacterial Overgrowth in Parkinson's Disease
Trial
Phase 2
Completed
Feb. 29, 2024
A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia
Trial
Phase 1
Withdrawn
Feb. 29, 2024
Safety and Efficacy of State-of-the-Art Exoskeleton Technology to Improve Mobility in Parkinson's Disease
Trial
N/A
Terminated
Feb. 27, 2024
Effect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's Disease
Trial
N/A
Unknown
Feb. 27, 2024
Ambroxol as a Treatment for Parkinson's Disease Dementia
Trial
Phase 2
Unknown
Feb. 27, 2024
High Fiber in Parkinson's Disease
Trial
Phase 1
Unknown
Feb. 25, 2024
Wolf-Parkinson-White Syndrome and Asymptomatic Pre-excitation in Africa (a Multicenter WPW African Registry)
Trial
N/A
Unknown
Feb. 25, 2024
Speech and Voice Outcomes Following HD-tDCS Over the Left SMA
Trial
N/A
Not yet recruiting
Feb. 25, 2024
Focal Muscle Vibration in Parkinson's Disease
Trial
N/A
Unknown
Feb. 25, 2024
Behavioural Profiling of Disease-related Cognitive and Motor Impairment in PD
Trial
N/A
Completed
Feb. 22, 2024
Biodex Balance System in Patients With Parkinson's Disease
Trial
N/A
Unknown
Feb. 21, 2024
Remote Programming for Deep Brain Stimulation in Parkinson's Disease.
Trial
N/A
Unknown
Feb. 21, 2024
Effect of Sensorimotor Training on Upper Extremity in Parkinson's Patients
Trial
N/A
Completed
Feb. 21, 2024
LONG TERM EFFECTS OF SPINAL CORD STIMULATION
Trial
N/A
Unknown
Feb. 21, 2024
tDCS for Dual-task Performance in Patients With PD
Trial
N/A
Completed
Feb. 19, 2024
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Trial
Phase 2
Completed
Feb. 19, 2024
Optimal Verbal Instruction to Improve Walking for PD
Trial
N/A
Completed
Feb. 19, 2024
A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in PD Patients
Trial
N/A
Completed
Feb. 15, 2024
The Experience in Neurorehabilitation Setting: a Qualitative Study
Trial
N/A
Unknown
Feb. 15, 2024